Abstract 5711: Global Study of Cardiovascular Inflammation and 10-year Cardiovascular Risk in Patients with Atherosclerotic Cardiovascular Disease With and Without Chronic Kidney Disease: Analysis from the POSEIDON Study
Introduction: Patients with ASCVD remain at high risk of recurrent CV events, despite preventive therapies. Risk varies widely even among such patients, and tools such as the Secondary Manifestations of ARTerial disease 2 (SMART2) risk prediction calculator (which has been validated in different regions) may help to...